Enveric Biosciences Q4 EPS $(0.50) Up From $(57.96) YoY

Benzinga Newsdesk www.benzinga.com Negative 49.7%

Neg 49.7% Neu 0% Pos 0%

Enveric Biosciences (NASDAQ:ENVB) reported quarterly losses of $(0.50) per share. This is a 99.14 percent increase over losses of $(57.96) per share from the same period last year.